NH TherAguix is a clinical stage company, specializing in nanomedicine for cancer radiotherapy. The Company produces and develops its drug candidate AGuIX, for the treatment of solid cancers, with the potential to increase the survival rate of cancer patients, as well as their quality of life when it is combined with radiotherapy.
|Employees (est.) (Mar 2020)||8||(+60%)|
NH TherAguix total Funding
NH TherAguix latest funding size
Time since last funding
|a year ago|
NH TherAguix investors
|Omnes Capital, BPI France, Supernova Invest, Arbevel|
When was NH TherAguix founded?
NH TherAguix was founded in 2015.
How many employees does NH TherAguix have?
NH TherAguix has 8 employees.
Who are NH TherAguix competitors?
Competitors of NH TherAguix include Cullgen, NorInvent and Shanghai Henlius Biotech.
Where is NH TherAguix headquarters?
NH TherAguix headquarters is located at 43 Boulevard du 11 Novembre 1918, Villeurbanne.
Where are NH TherAguix offices?
NH TherAguix has an office in Villeurbanne.
How many offices does NH TherAguix have?
NH TherAguix has 1 office.
Receive alerts for 300+ data fields across thousands of companies